Tumors express both unique TSTA and crossprotective 44 kDa oncofetal antigen

Tumors of inbred rodents and humans generally express a shared tumor-associated transplantation antigen (TATA)-like oncofetal antigen (OFA) and tumor-specific transplantation antigen (TSTA), which stimulate cytotoxic T lymphocyte (CTL) tumor rejection responses. Immunoregulatory CD8 + OFA-specific suppressor T cells are also stimulated, which promote tumor development via interleukin 10 secretion, inhibiting CTL function. Here, Joseph Coggin and colleagues argue that future investigations must distinguish responses to OFA and TSTA.